Camp4 Therapeutics Corp Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin -14,083.14%-7,943.40%
EBIT Margin -14,822.57%-8,142.33%
EBITDA Margin -14,083.14%-7,943.40%
Operating Margin -14,822.57%-8,142.33%
Net Margin -14,083.14%-7,943.40%
FCF Margin -12,809.43%-7,061.50%
Efficiency
Assets Average 66.63M
Equity Average -30.29M
Invested Capital -123.73M63.30M
Asset Utilization Ratio 0.01
Leverage & Solvency
Interest Coverage Ratio -235.81-0.00M
Equity Ratio -2.250.81
Times Interest Earned -235.81-0.00M
Valuation
Enterprise Value -38.38M41.20M
Market Capitalization 105.24M
Return Ratios
Return on Sales -140.83%-79.43%
Return on Capital Employed -0.93%
Return on Assets -0.78%
Return on Equity 1.71%